Zhou Xinji intends to acquire 13% stake in Jiangsu Jiujiujiu Technology Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company (SZSE:002411) for about CNY 390 million on November 2, 2020. Zhou Xinji signed an equity purchase agreement to acquire 13% stake in Jiangsu Jiujiujiu Technology Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company (SZSE:002411) on November 12, 2020. The consideration will be paid in cash. Under the terms of transaction, a deposit of CNY 30 million shall be paid within 10 days after the entry into force of this agreement, and the deposit will be automatically transferred to the transaction price of the transaction on the delivery date of the underlying asset. The remaining transfer price of transaction (that is, the remaining CNY 360 million after deducting the automatically transferred transaction price of the deposit) shall be paid in installments within three years from the delivery date, and the annual payment amount shall not be less than one-third of the total price of the transaction One, namely CNY 120 million. In a separate transaction, Shenzhen Capchem Technology Co., Ltd. (SZSE:300037) signed a framework agreement to acquire 74.24% stake in Jiangsu Jiujiujiu Technology Co., Ltd. from YanAn Bicon Pharmaceutical Listed Company (SZSE:002411) for CNY 2.2 billion. For the financial year ended December 31, 2019, Jiangsu Jiujiujiu Technology had total assets of CNY 2.38 billion, net assets of CNY 1.4 billion, revenue of CNY 1.4 billion, operating profit of CNY 153.8 million and net profit of CNY 116.12 million. The transaction is subject to shareholders of YanAn Bicon Pharmaceutical. The transaction is approved in 10th meeting of the fifth Directorate and the 9th meeting of the fifth Board of supervisors of YanAn Bicon Pharmaceutical on November 12, 2020. As of December 28, 2020, the transaction was approved in the 10th extraordinary shareholders meeting of 2020 of YanAn Bicon Pharmaceutical Listed Company.